 |
9 Diseases |  |
2 Trials |
|
2 Trials |  |
69 News |  |
| «12 |
- |||| difamilast (MM36) / Otsuka, Medimetriks
Trial completion, Enrollment change: A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis (clinicaltrials.gov) - Feb 5, 2015
P2, N=94, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Active, not recruiting --> Completed | N=120 --> 94
- | difamilast (MM36) / Otsuka, Medimetriks
New P1 trial: A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects (clinicaltrials.gov) - Jan 8, 2015
P1, N=32, Recruiting, Sponsor: Otsuka Pharmaceutical Co., Ltd.
- ||| difamilast (MM36) / Otsuka, Medimetriks
Enrollment closed: A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis (clinicaltrials.gov) - Dec 13, 2014
P2, N=120, Active, not recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Active, not recruiting --> Completed | N=120 --> 94 Enrolling by invitation --> Active, not recruiting
- |||| difamilast (MM36) / Otsuka, Medimetriks
Enrollment open: A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis (clinicaltrials.gov) - Jul 2, 2014
P2, N=120, Enrolling by invitation, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Enrolling by invitation --> Active, not recruiting Not yet recruiting --> Enrolling by invitation
- ||| difamilast (MM36) / Otsuka, Medimetriks
Trial initiation date: A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis (clinicaltrials.gov) - Mar 29, 2014
P2, N=120, Not yet recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Not yet recruiting --> Enrolling by invitation Initiation date: Mar 2014 --> Jun 2014
- ||| difamilast (MM36) / Otsuka, Medimetriks
Enrollment change: A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis (clinicaltrials.gov) - Mar 29, 2014
P2, N=120, Not yet recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Initiation date: Mar 2014 --> Jun 2014 N=256 --> 120
- ||||| difamilast (MM36) / Otsuka, Medimetriks
New P2 trial: A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis (clinicaltrials.gov) - Feb 19, 2014
P2, N=120, Not yet recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
- ||| difamilast (MM36) / Otsuka, Medimetriks
Trial completion: A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis (clinicaltrials.gov) - Jan 15, 2014
P1, N=92, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
N=256 --> 120 Recruiting --> Completed
- ||| difamilast (MM36) / Otsuka, Medimetriks
New P1 trial: A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis (clinicaltrials.gov) - Oct 3, 2012
P1, N=92, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.